EZH1 has been demonstrated to play a key role in the development of various cancers (Wassef et al., 2019), such as multiple myeloma (Nakagawa et al., 2019), lymphoma (Kagiyama et al., 2021), and thyroid tumors (Jung et al., 2018). The gene discussed is EZH1; the disease is plasma cell myeloma.